TerrAscend (OTCMKTS:TSNDF – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.04, Zacks reports. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%. The firm had revenue of $74.35 million during the quarter, compared to analyst estimates of $72.37 million.
TerrAscend Price Performance
TSNDF stock opened at $0.47 on Friday. TerrAscend has a 1-year low of $0.38 and a 1-year high of $2.20. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. The business has a 50 day simple moving average of $0.57 and a two-hundred day simple moving average of $0.87.
Wall Street Analyst Weigh In
Separately, Atb Cap Markets downgraded TerrAscend from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Recommended Stories
- Five stocks we like better than TerrAscend
- 3 Grocery Stocks That Are Proving They Are Still Essential
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Why Invest in High-Yield Dividend Stocks?
- 3 Stocks to Buy While Others Stay on the Sidelines
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
